Nephropathy News and Research

RSS

Nephropathy is a broad medical term used to denote disease or damage of the kidney, which can eventually result in kidney failure. The primary and most obvious functions of the kidney are to excrete any waste products and to regulate the water and acid-base balance of the body – therefore loss of kidney function is a potentially fatal condition.

Fewer diabetics end up in hospital

According to new research from the U.S. Centers for Disease Control and Prevention (CDC), Americans with diabetes are less likely than they were a decade ago, to need hospitalization for serious complications such as kidney failure.

14 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes -- all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Scientists at Joslin Diabetes Center have investigated PKC-beta -- a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes -- for more than two decades.

10 Jun 2005

Unique therapeutic strategy to combat cachexia

Researchers at Oregon Health & Science University's Doernbecher Children's Hospital have uncovered a unique therapeutic strategy to combat cachexia - severe malnutrition and physical wasting away - in children and adults with chronic kidney disease (CKD). The study is published in the June issue of the Journal of Clinical Investigation.

9 Jun 2005

Bone Care International issued new patent

Bone Care International has announced that the U.S. Patent and Trademark Office has issued to it U.S. Patent Number 6,903,083 entitled "Stabilized hydroxyvitamin D."

8 Jun 2005

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

A Davidson woman has been successfully treated for her Type 1 diabetes through a procedure performed at Carolinas Medical Center. Paul F. Gores, M.D., has led a multi-disciplinary team through a series of three pancreatic islet cell transplants since the summer of 2003. The result is a patient who is now insulin-free.

8 Jun 2005

Suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer

A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.

5 Jun 2005

Medication errors dramatically reduced in patients with kidney disease

A first of its kind study has shown a dramatic reduction in medication errors in patients with chronic kidney disease when Kaiser Permanente Colorado researchers teamed with pharmacists to use a computerized system to electronically screen prescriptions for unsafe medication orders.

3 Jun 2005

La Jolla Pharmaceutical provides update on Riquent

La Jolla Pharmaceutical Company today announced that it has received "fast track" designation for Riquent (abetimus sodium) for the treatment of lupus renal disease from the U.S. Food and Drug Administration (FDA).

31 May 2005

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

A post-market analysis of cholesterol-lowering drugs called statins indicates that some of the most serious side effects may be higher in one of the newest drugs, rosuvastatin (Crestor). The drug is the strongest statin available because it has the greatest effect per milligram on low-density lipoprotein ("bad" cholesterol).

26 May 2005

Narcotic medications can safely and effectively ease severe, chronic pain in older people

Narcotic medications can safely and effectively ease severe, chronic pain in older people with little risk that these patients will seek ever-increasing doses, UCSF medical scientists have found. Younger patients, however, are likely to want to rapidly increase their medication dose, the researchers found, posing serious potential health consequences.

23 May 2005

Australian Medical Association indigenous health report card focuses on low birth weight babies

Australian Medical Association (AMA) President, Dr Bill Glasson, has launched Lifting the Weight, the AMA's fourth report card on Aboriginal and Torres Strait Islander health.

22 May 2005

Cystatin-C, a new blood test for kidney function, is a better predictor of death and cardiovascular risk among the elderly

Investigators for NHLBI's Cardiovascular Health Study compared the two measures of kidney function, cystatin-C and the standard test creatinine, as predictors of death from all causes, death from cardiovascular causes, and incidence of heart attack and stroke among 4,637 elderly participants in the study.

20 May 2005

New kidney test better elder mortality predictor

A study at the San Francisco VA Medical Center (SFVAMC) has found that a test of kidney function that measures blood levels of cystatin C -- a protein produced by most cells in the body -- is a far more accurate predictor of mortality risk in elderly people than the current standard kidney function test, which measures levels of the protein creatinine.

20 May 2005

Narcotic medications can safely and effectively ease severe, chronic pain in older people

Narcotic medications can safely and effectively ease severe, chronic pain in older people with little risk that these patients will seek ever-increasing doses, University of California, San Francisco (UCSF) medical scientists have found. Younger patients, however, are likely to want to rapidly increase their medication dose, the researchers found, posing serious potential health consequences.

20 May 2005

Patients with type 2 diabetes who participate in group education programs require less medication

Group-based education resulted in improved diabetes control as reflected by blood glucose levels and patients’ knowledge of diabetes. Evidence also suggested that participants in diabetes group education programs may reduce their blood pressure and body weight and increase self-empowerment, quality of life, self-management skills and treatment satisfaction.

18 May 2005

Nephropathy News and Research

Further Reading

Fewer diabetics end up in hospital

Tight glucose control lowers CVD by about 50 percent in diabetes

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Link between PKC enzyme and kidney disease in diabetes confirmed

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Unique therapeutic strategy to combat cachexia

Bone Care International issued new patent

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

Suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer

Medication errors dramatically reduced in patients with kidney disease

La Jolla Pharmaceutical provides update on Riquent

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

Narcotic medications can safely and effectively ease severe, chronic pain in older people

Australian Medical Association indigenous health report card focuses on low birth weight babies

Cystatin-C, a new blood test for kidney function, is a better predictor of death and cardiovascular risk among the elderly

New kidney test better elder mortality predictor

Narcotic medications can safely and effectively ease severe, chronic pain in older people

Patients with type 2 diabetes who participate in group education programs require less medication

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News